Reticulocyte Hemoglobin Equivalent (Ret-He) as a Marker of Iron Deficiency Anemia in Acutely Ill Hospitalized

Madhumati Suhas Otiv1, Sarita Verma2, Suman Garag1

  • 1Department of Pediatrics, K.E.M Hospital and Research Center, Rasta Peth, Pune, 411011, India.

Insights

Reticulocyte hemoglobin equivalent (Ret-He) is a superior diagnostic marker for iron deficiency anemia (IDA) in acutely ill children compared to serum ferritin. This study highlights Ret-He

Area of Science:

  • Pediatric Hematology
  • Diagnostic Biomarkers
  • Anemia Research

Background:

  • Iron deficiency anemia (IDA) is a common condition in acutely ill children.
  • Accurate and timely diagnosis is crucial for effective management.
  • Serum ferritin is a traditional marker, but its utility can be affected by inflammation.

Purpose of the Study:

  • To evaluate the diagnostic utility of reticulocyte hemoglobin equivalent (Ret-He) for identifying IDA in acutely ill hospitalized children.
  • To compare the diagnostic performance of Ret-He with serum ferritin.
  • To determine optimal cut-off values for both markers in this pediatric population.

Main Methods:

  • Patients were categorized into IDA, non-anemia-iron-deficiency (NAID), and normal groups after excluding confounding conditions.
  • Diagnostic utility indices, including sensitivity, specificity, and predictive values, were calculated for Ret-He and serum ferritin.
  • Receiver-operating-characteristic (ROC) curve analysis was used to determine optimal cut-off points.

Main Results:

  • Ret-He levels were significantly lower in the IDA group compared to other groups (p < 0.001).
  • Serum ferritin levels did not show a significant difference between groups (p = 0.062).
  • Ret-He demonstrated higher sensitivity (87.2%) and specificity (80.9%) for IDA detection compared to serum ferritin (58.8% and 66.7%, respectively).

Conclusions:

  • Ret-He exhibits superior diagnostic utility for identifying IDA in acutely ill hospitalized children compared to serum ferritin.
  • The optimal cut-off for serum ferritin in this cohort was higher than the WHO reference standard.
  • Ret-He serves as a valuable and potentially more reliable biomarker for IDA diagnosis in this clinical setting.
Abstract

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...